Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.24.1.1.u2
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
May 07, 2024
Dec. 21, 2021
Jan. 31, 2024
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Net loss       $ 31,600,000 $ 9,100,000  
Accumulated deficit       781,102,000   $ 749,524,000
Cash, cash equivalents, restricted cash and short-term investments       62,700,000    
Gross proceeds from its underwritten offering   $ 16,000,000.0   75,000,000.0    
Other receivables       $ 2,100,000   $ 2,100,000
Unfounded exercise price per share       $ 0.0001    
Warrants exercise price   $ 9.75        
Shares of common stock issuable upon exercise of warrants       1,788,000    
Subsequent Event [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Gross proceeds from its underwritten offering $ 70,200,000          
Loan and Security Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Warrants to purchase shares     $ 2,400,000      
Warrants exercise price     $ 4.75      
2024 Loan Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Warrants exercise price       $ 4.75    
Shares of common stock issuable upon exercise of warrants       505,263  
2024 Loan Agreement [Member] | Subsequent Event [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Warrants exercise price $ 4.07